GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer

Figure 2

The Kaplan-Meier survival analysis of CRC patients. (a) The Kaplan-Meier survival analysis of CRC patients (), including 64 high GRHL3 expression and 36 low GRHL3 expression according to GRHL3 immunostaining scores: is low GRHL3 expression and belongs to high GRHL3 expression. versus the low or no GRHL3 expression. (b) The Kaplan-Meier survival analysis of well differentiation in CRC patients. (c) The Kaplan-Meier survival analysis of middle differentiation in CRC patients. versus the low or no GRHL3 expression. (d) The Kaplan-Meier survival analysis of poor differentiation in CRC patients. versus the low or no GRHL3 expression. (e) The Kaplan-Meier survival analysis of in CRC patients. (f) The Kaplan-Meier survival analysis of in CRC patients. versus the low or no GRHL3 expression.

(a)

(b)

(c)

(d)

(e)

(f)